Filing Details
- Accession Number:
- 0001209191-10-013596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-02 12:00:00
- Reporting Period:
- 2010-02-26
- Filing Date:
- 2010-03-02
- Accepted Time:
- 2010-03-02 17:51:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100962 | Endo Pharmaceuticals Holdings Inc | ENDP | Pharmaceutical Preparations (2834) | 134022871 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1455549 | J Edward Sweeney | C/O Endo Pharmaceuticals Holdings Inc. 100 Endo Boulevard Chadds Ford PA 19317 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.01 Per Share | Acquisiton | 2010-02-26 | 1,110 | $0.00 | 1,805 | No | 4 | M | Direct | |
| Common Stock, Par Value $.01 Per Share | Disposition | 2010-03-01 | 695 | $21.69 | 1,110 | No | 4 | S | Direct | |
| Common Stock, Par Value $.01 Per Share | Disposition | 2010-03-01 | 1,110 | $22.34 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | 2007 Stock Incentive Plan Restricted Stock Units(RSUs) | Disposition | 2010-02-26 | 1,110 | $0.00 | 1,110 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,329 | 2010-02-26 | 2010-02-26 | No | 4 | M | Direct |
Footnotes
- This represents the vesting of restricted stock units granted to Mr. Sweeney on February 26, 2009. Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of common stock of Endo Pharmaceuticals Holdings Inc.
- These shares represent common stock received by Mr. Sweeney on February 22, 2010 upon the vesting of RSUs, as reported on Form 4 on February 23, 2010.
- Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of common stock of Endo Pharmaceuticals Holdings Inc.
- Twenty-five percent (25%) of Mr. Sweeney's February 26, 2009 grant of restricted stock units (RSUs) generally vest 25% on each of February 26, 2010, February 26, 2011, February 26, 2012 and February 26, 2013. The 1,110 shown here is the amount that vested on February 26, 2010. Upon vesting, we consider the underlying RSUs to be expired.
Billionaire Hedge Funds
